-+ 0.00%
-+ 0.00%
-+ 0.00%

Zhitong Finance App News, Huabei Pharmaceutical (600812.SH) issued an announcement on abnormal stock trading fluctuations, stating that the company is concerned that the market is paying a lot of attention to hot concepts related to the “plague” recently. After verification, the company's instructions for injectable streptomycin sulfate show that it can be used alone to treat tularemia or in combination with other antimicrobials to treat plague, inguinal granuloma, brucellosis, rat bite fever, etc. This product is the company's traditional antibiotic. The sales revenue scale of this product is small in 2025 and January-June 2026, and will not have a significant impact on the company's overall business performance.

Zhitongcaijing·10/09/2026 12:49:03
Listen to the news
Zhitong Finance App News, Huabei Pharmaceutical (600812.SH) issued an announcement on abnormal stock trading fluctuations, stating that the company is concerned that the market is paying a lot of attention to hot concepts related to the “plague” recently. After verification, the company's instructions for injectable streptomycin sulfate show that it can be used alone to treat tularemia or in combination with other antimicrobials to treat plague, inguinal granuloma, brucellosis, rat bite fever, etc. This product is the company's traditional antibiotic. The sales revenue scale of this product is small in 2025 and January-June 2026, and will not have a significant impact on the company's overall business performance.